MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,547,639 | +25.0% | 221,175 | +80.7% | 0.00% | +100.0% |
Q2 2023 | $2,837,939 | +4.3% | 122,431 | +4.6% | 0.00% | 0.0% |
Q1 2023 | $2,720,245 | +30.4% | 117,101 | -18.6% | 0.00% | 0.0% |
Q4 2022 | $2,086,850 | -29.1% | 143,822 | -6.8% | 0.00% | -50.0% |
Q3 2022 | $2,945,000 | +13.3% | 154,329 | +7.8% | 0.00% | +100.0% |
Q2 2022 | $2,600,000 | -26.1% | 143,101 | +2.6% | 0.00% | -50.0% |
Q1 2022 | $3,516,000 | -2.7% | 139,540 | +6.6% | 0.00% | 0.0% |
Q4 2021 | $3,612,000 | -9.2% | 130,870 | +6.3% | 0.00% | 0.0% |
Q3 2021 | $3,977,000 | +16.9% | 123,162 | +10.7% | 0.00% | 0.0% |
Q2 2021 | $3,402,000 | -2.7% | 111,236 | -3.1% | 0.00% | 0.0% |
Q1 2021 | $3,496,000 | +89.0% | 114,802 | +22.7% | 0.00% | +100.0% |
Q4 2020 | $1,850,000 | +74.5% | 93,572 | +15.1% | 0.00% | 0.0% |
Q3 2020 | $1,060,000 | +19.0% | 81,293 | +3.5% | 0.00% | 0.0% |
Q2 2020 | $891,000 | +9.1% | 78,575 | +37.7% | 0.00% | 0.0% |
Q1 2020 | $817,000 | +40.6% | 57,061 | +167.4% | 0.00% | 0.0% |
Q4 2019 | $581,000 | -0.2% | 21,337 | +4.9% | 0.00% | 0.0% |
Q3 2019 | $582,000 | +1906.9% | 20,340 | +1241.7% | 0.00% | – |
Q1 2017 | $29,000 | +3.6% | 1,516 | -5.2% | 0.00% | – |
Q4 2016 | $28,000 | +21.7% | 1,600 | +41.5% | 0.00% | – |
Q3 2016 | $23,000 | -42.5% | 1,131 | +5.8% | 0.00% | – |
Q1 2016 | $40,000 | -42.9% | 1,069 | -34.0% | 0.00% | – |
Q4 2015 | $70,000 | -32.7% | 1,620 | -41.5% | 0.00% | -100.0% |
Q3 2015 | $104,000 | +52.9% | 2,771 | +38.6% | 0.00% | 0.0% |
Q4 2014 | $68,000 | -28.4% | 2,000 | -19.1% | 0.00% | 0.0% |
Q3 2014 | $95,000 | -87.5% | 2,472 | -87.4% | 0.00% | -87.5% |
Q2 2014 | $761,000 | +10.3% | 19,549 | -3.1% | 0.01% | 0.0% |
Q1 2014 | $690,000 | -24.3% | 20,167 | -53.6% | 0.01% | -20.0% |
Q4 2013 | $912,000 | +32.9% | 43,478 | +48.9% | 0.01% | +25.0% |
Q3 2013 | $686,000 | -10.4% | 29,196 | +2.4% | 0.01% | -20.0% |
Q2 2013 | $766,000 | – | 28,507 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |